A PD-1/PD-L1-Sensitive Co-culture-Based Primary T-Cell Activation Assay.

Area of Science:

• Immunology
• Cell Biology
• Assay Development

Background:

• Programmed cell death protein 1 (PD-1) regulates T-cell activity and immune responses.
• The PD-1/PD-L1 pathway is a key target for immunotherapies.
• Existing methods for assessing PD-1/PD-L1 interactions require refinement.

Purpose of the Study:

• To develop and validate a novel in vitro co-culture assay for evaluating PD-1/PD-L1 immune checkpoint inhibitors.
• To quantify T-cell activation in the presence of PD-1/PD-L1 signaling.
• To assess the potency of molecules targeting the PD-1/PD-L1 pathway.

Main Methods:

• Co-culture of human peripheral blood mononuclear cells (PBMCs) with Chinese hamster ovary (CHO-K1) cells engineered to express PD-L1 and a T-cell receptor activator (TCRAct).
• Mimicking antigen-presenting cells (APCs) with CHO-K1/TCRAct/hPD-L1 cells to activate T cells via TCR.
• Monitoring T-cell activation using flow cytometry, analyzing surface markers like CD69, CD25, HLA-DR, and PD-1.

Main Results:

• The assay successfully demonstrates T-cell activation (TCA) via TCR signaling.
• PD-1/PD-L1 immune checkpoint signaling diminishes T-cell activation in the co-culture system.
• Blocking the PD-1/PD-L1 interaction leads to increased expression of T-cell activation markers.

Conclusions:

• The developed in vitro co-culture assay provides a robust method for testing PD-1/PD-L1 checkpoint inhibitor potency.
• This assay enables the study of T-cell modulation by the PD-1/PD-L1 pathway.
• The findings support the utility of this assay in preclinical drug development for immunotherapies.